- Home
- CUE vs OM Comparison
CUE vs OM Comparison
Compare CUE & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- OM
- Stock Information
- Founded
- CUE 2014
- OM 2003
- Country
- CUE United States
- OM United States
- Employees
- CUE N/A
- OM N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CUE Health Care
- OM Health Care
- Exchange
- CUE Nasdaq
- OM Nasdaq
- Market Cap
- CUE 60.6M
- OM 50.5M
- IPO Year
- CUE 2018
- OM 2020
- Fundamental
- Price
- CUE $0.92
- OM $12.58
- Analyst Decision
- CUE Strong Buy
- OM Strong Buy
- Analyst Count
- CUE 4
- OM 3
- Target Price
- CUE $4.75
- OM $60.00
- AVG Volume (30 Days)
- CUE 151.6K
- OM 98.0K
- Earning Date
- CUE 05-08-2025
- OM 05-07-2025
- Dividend Yield
- CUE N/A
- OM N/A
- EPS Growth
- CUE N/A
- OM N/A
- EPS
- CUE N/A
- OM N/A
- Revenue
- CUE $9,532,000.00
- OM $113,689,000.00
- Revenue This Year
- CUE $73.11
- OM $8.98
- Revenue Next Year
- CUE $11.02
- OM $12.74
- P/E Ratio
- CUE N/A
- OM N/A
- Revenue Growth
- CUE 149.53
- OM N/A
- 52 Week Low
- CUE $0.45
- OM $5.85
- 52 Week High
- CUE $2.26
- OM $78.30
- Technical
- Relative Strength Index (RSI)
- CUE 33.15
- OM 60.43
- Support Level
- CUE $0.95
- OM $5.85
- Resistance Level
- CUE $1.03
- OM $11.62
- Average True Range (ATR)
- CUE 0.08
- OM 1.30
- MACD
- CUE 0.01
- OM 0.53
- Stochastic Oscillator
- CUE 3.85
- OM 100.00
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.